Anytime it tries to make a break the last two days it gets bumped right back down on 700 share sales below the bid. I would think this was someone trying to manipulate the price in order to accumulate at these levels, but with the volume so thin I don't know how much accumulating can be happening.
I am long and want to see this stock run as much as anyone else, but I don't see how the CEO working overtime can speed up a clinical trial? Isn't the time frame based on a specific date range that the patients are using the drug. They can't change that date range can they? It is going to take retail speculation to get this to $1 and avoid a split before results come out. If it does split and resluts are good the higher stock price will not matter.